Search research articles
Contact Us
Filters
Showing results (241-250 of 274) with videos related to
Page
of 28
Sort By:
Journal of Virology
|
September 11, 2015
A Highly Immunogenic and Protective Middle East Respiratory Syndrome Coronavirus Vaccine Based on a Recombinant Measles Virus Vaccine Platform
Anna H Malczyk, Alexandra Kupke, Steffen Prüfer, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 12, 2017
Favipiravir and Ribavirin Treatment of Epidemiologically Linked Cases of Lassa Fever
Vanessa N Raabe, Gerrit Kann, Bruce S Ribner, et al.
The Lancet. Infectious Diseases
|
April 24, 2020
Safety and immunogenicity of a modified vaccinia virus Ankara vector vaccine candidate for Middle East respiratory syndrome: an open-label, phase 1 trial
Till Koch, Christine Dahlke, Anahita Fathi, et al.
Viruses
|
August 28, 2021
Intranasal Administration of a Monoclonal Neutralizing Antibody Protects Mice against SARS-CoV-2 Infection
Sandro Halwe, Alexandra Kupke, Kanika Vanshylla, et al.
Vaccine
|
June 6, 2020
Humoral and cellular immune response induced by rVSVΔG-ZEBOV-GP vaccine among frontline workers during the 2013-2016 West Africa Ebola outbreak in Guinea
Yap Boum, Aitana Juan-Giner, Matt Hitchings, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 1, 2019
Postexposure Prophylaxis With rVSV-ZEBOV Following Exposure to a Patient With Ebola Virus Disease Relapse in the United Kingdom: An Operational, Safety, and Immunogenicity Report
Chris Davis, Tom Tipton, Suleman Sabir, et al.
Cell
|
July 17, 2020
Longitudinal Isolation of Potent Near-Germline SARS-CoV-2-Neutralizing Antibodies from COVID-19 Patients
Christoph Kreer, Matthias Zehner, Timm Weber, et al.
Cell
|
September 18, 2020
Longitudinal Isolation of Potent Near-Germline SARS-CoV-2-Neutralizing Antibodies from COVID-19 Patients
Christoph Kreer, Matthias Zehner, Timm Weber, et al.
Nature Communications
|
July 19, 2022
Increased neutralization and IgG epitope identification after MVA-MERS-S booster vaccination against Middle East respiratory syndrome
Anahita Fathi, Christine Dahlke, Verena Krähling, et al.
Scientific Reports
|
November 10, 2019
Humoral Immunogenicity and Efficacy of a Single Dose of ChAdOx1 MERS Vaccine Candidate in Dromedary Camels
Naif Khalaf Alharbi, Ibrahim Qasim, Abdulrahman Almasoud, et al.
Page
of 28
Search research articles
Search
Showing results (241-250 of 274) with videos related to
Sort By:
Page
of 28
Journal of Virology
|
September 11, 2015
A Highly Immunogenic and Protective Middle East Respiratory Syndrome Coronavirus Vaccine Based on a Recombinant Measles Virus Vaccine Platform
Anna H Malczyk, Alexandra Kupke, Steffen Prüfer, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 12, 2017
Favipiravir and Ribavirin Treatment of Epidemiologically Linked Cases of Lassa Fever
Vanessa N Raabe, Gerrit Kann, Bruce S Ribner, et al.
The Lancet. Infectious Diseases
|
April 24, 2020
Safety and immunogenicity of a modified vaccinia virus Ankara vector vaccine candidate for Middle East respiratory syndrome: an open-label, phase 1 trial
Till Koch, Christine Dahlke, Anahita Fathi, et al.
Viruses
|
August 28, 2021
Intranasal Administration of a Monoclonal Neutralizing Antibody Protects Mice against SARS-CoV-2 Infection
Sandro Halwe, Alexandra Kupke, Kanika Vanshylla, et al.
Vaccine
|
June 6, 2020
Humoral and cellular immune response induced by rVSVΔG-ZEBOV-GP vaccine among frontline workers during the 2013-2016 West Africa Ebola outbreak in Guinea
Yap Boum, Aitana Juan-Giner, Matt Hitchings, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 1, 2019
Postexposure Prophylaxis With rVSV-ZEBOV Following Exposure to a Patient With Ebola Virus Disease Relapse in the United Kingdom: An Operational, Safety, and Immunogenicity Report
Chris Davis, Tom Tipton, Suleman Sabir, et al.
Cell
|
July 17, 2020
Longitudinal Isolation of Potent Near-Germline SARS-CoV-2-Neutralizing Antibodies from COVID-19 Patients
Christoph Kreer, Matthias Zehner, Timm Weber, et al.
Cell
|
September 18, 2020
Longitudinal Isolation of Potent Near-Germline SARS-CoV-2-Neutralizing Antibodies from COVID-19 Patients
Christoph Kreer, Matthias Zehner, Timm Weber, et al.
Nature Communications
|
July 19, 2022
Increased neutralization and IgG epitope identification after MVA-MERS-S booster vaccination against Middle East respiratory syndrome
Anahita Fathi, Christine Dahlke, Verena Krähling, et al.
Scientific Reports
|
November 10, 2019
Humoral Immunogenicity and Efficacy of a Single Dose of ChAdOx1 MERS Vaccine Candidate in Dromedary Camels
Naif Khalaf Alharbi, Ibrahim Qasim, Abdulrahman Almasoud, et al.
Page
of 28